Sean Spencer
@seanspencermdphd.bsky.social
📤 27
📥 6
📝 0
Physician-scientist focused on impactful diet and microbiome discovery in Neurogastroenterology
reposted by
Sean Spencer
Bernat Olle
about 1 year ago
Today our team published additional results from the Phase 2 CONSORTIUM study for our lead candidate, VE303, a potential first-in-class Live Biotherapeutic Product which is being evaluated for prevention of recurrent Clostridioides difficile infection (rCDI). full-text access:
rdcu.be/d5ovX
loading . . .
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection
Nature Medicine - Results of multi-omic profiling of the microbiome and host immunity of individuals treated with VE303 to prevent recurrent Clostridioides difficile infection in the context of a...
https://rdcu.be/d5ovX
1
20
5
you reached the end!!
feeds!
log in
